for the Period Ended 31 May 2024
Company Information - 3 | |
Report of the Directors - 4 | |
Balance sheet - 5 | |
Additional notes - 7 | |
Balance sheet notes - 10 |
for the Period Ended 31 May 2024
Director: |
|
|
Registered office: |
GBR |
|
Company Registration Number: |
|
|
The directors present their report with the financial statements of the company for the period ended 31 May 2024
Principal Activities
Additional information
During the first period of trading, the Company achieved a turnover of GBP 3,620,971.33, establishing a robust presence in the mainland United Kingdom. Our balance sheet reflects a period of dynamic growth and strategic investment. Overall, our financial statements illustrate a company in a dynamic phase of growth one that is prioritizing strategic investment and efficient capital management to build a strong foundation for future profitability and market expansion.
Directors
The directors shown below have held office during the whole of the period from 01 January 2023 to 31 May 2024
This report was approved by the board of directors on
And Signed On Behalf Of The Board By:
Name:
Status: Director
As at
Notes |
17 months to 31 May 2024 £ |
13 months to 31 Dec 2022 £ |
|
---|---|---|---|
Fixed assets | |||
Tangible assets: | 4 |
|
|
Total fixed assets: |
|
|
|
Current assets | |||
Debtors: |
|
||
Cash at bank and in hand: |
|
||
Total current assets: |
|
||
Creditors: amounts falling due within one year: |
( |
||
Net current assets (liabilities): |
( |
||
Total assets less current liabilities: |
|
|
|
Creditors: amounts falling due after more than one year: |
( |
||
Total net assets (liabilities): |
( |
|
The notes form part of these financial statements
As at 31 May 2024
Notes |
17 months to 31 May 2024 £ |
13 months to 31 Dec 2022 £ |
|
---|---|---|---|
Capital and reserves | |||
Called up share capital: |
|
|
|
Profit and loss account: |
( |
||
Shareholders funds: |
( |
|
This report was approved by the board of directors on
And Signed On Behalf Of The Board By:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 31 May 2024
Basis of measurement and preparation
for the Period Ended 31 May 2024
17 months to 31 May 2024 |
13 months to 31 Dec 2022 |
|
---|---|---|
Average number of employees during the period |
|
|
for the Period Ended 31 May 2024
for the Period Ended 31 May 2024
Total | |
---|---|
Cost | £ |
At 01 January 2023 |
|
Additions |
|
Disposals |
( |
Revaluations |
|
Transfers |
|
At 31 May 2024 |
|
Depreciation | |
At 01 January 2023 |
|
Charge for year |
|
On disposals |
( |
Other adjustments |
|
At 31 May 2024 |
|
Net book value | |
At 31 May 2024 |
|
At 31 December 2022 |
|
Loan - Vannin Trading Limited
1,679.25
Loan - Vannin Healthcare Global Limited
57,921.90
Loan - Vannin Healthcare Holdings
238,903.11